Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.

Breman JG, Heymann DL, Lloyd G, McCormick JB, Miatudila M, Murphy FA, Muyembé-Tamfun JJ, Piot P, Ruppol JF, Sureau P, van der Groen G, Johnson KM.

J Infect Dis. 2016 Oct 15;214(suppl 3):S93-S101. Epub 2016 Jun 29.

2.

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.

Kuhn JH, Lofts LL, Kugelman JR, Smither SJ, Lever MS, van der Groen G, Johnson KM, Radoshitzky SR, Bavari S, Jahrling PB, Towner JS, Nichol ST, Palacios G.

Genome Announc. 2014 Nov 20;2(6). pii: e01178-14. doi: 10.1128/genomeA.01178-14.

3.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

4.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2014 May;159(5):1229-37. doi: 10.1007/s00705-013-1877-2. Epub 2013 Nov 5.

5.

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Lofts LL, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2013 Jun;158(6):1425-32. doi: 10.1007/s00705-012-1594-2. Epub 2013 Jan 29. No abstract available.

6.

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, Johnson KM, Kobinger G, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Saphire EO, Smither SJ, Swanepoel R, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Weidmann M, Nichol ST.

Arch Virol. 2013 Jan;158(1):301-11. doi: 10.1007/s00705-012-1454-0. Epub 2012 Sep 23. No abstract available.

7.

Beechnuts and outbreaks of nephropathia epidemica (NE): of mast, mice and men.

Clement J, Maes P, van Ypersele de Strihou C, van der Groen G, Barrios JM, Verstraeten WW, van Ranst M.

Nephrol Dial Transplant. 2010 Jun;25(6):1740-6. doi: 10.1093/ndt/gfq122. Epub 2010 Mar 17. No abstract available.

PMID:
20237057
8.

Mopeia virus-related arenavirus in natal multimammate mice, Morogoro, Tanzania.

Günther S, Hoofd G, Charrel R, Röser C, Becker-Ziaja B, Lloyd G, Sabuni C, Verhagen R, van der Groen G, Kennis J, Katakweba A, Machang'u R, Makundi R, Leirs H.

Emerg Infect Dis. 2009 Dec;15(12):2008-12. doi: 10.3201/eid1512.090864.

9.

Puumala virus reference strain for hantavirus serodiagnosis in France.

Clement J, van der Groen G, Maes P, Van Ranst M.

Eur J Clin Microbiol Infect Dis. 2010 Jan;29(1):1-2; author reply 3. doi: 10.1007/s10096-009-0829-y. No abstract available.

PMID:
19885688
10.

Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.

Beck IA, Crowell C, Kittoe R, Bredell H, Machaba M, Willamson C, Janssens W, Jallow S, van der Groen G, Shao Y, Jacob M, Samuel NM, de Rivera IL, Ngo-Giang-Huong N, Cassol S, Alemnji G, Frenkel LM.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):418-27. doi: 10.1097/QAI.0b013e31817ed7d7.

11.

Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Heeney JL, Rutjens E, Verschoor EJ, Niphuis H, ten Haaft P, Rouse S, McClure H, Balla-Jhagjhoorsingh S, Bogers W, Salas M, Cobb K, Kestens L, Davis D, van der Groen G, Courgnaud V, Peeters M, Murthy KK.

J Virol. 2006 Jul;80(14):7208-18.

12.

Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates.

Davis D, Donners H, Willems B, Ntemgwa M, Vermoesen T, van der Groen G, Janssens W.

J Med Virol. 2006 Jul;78(7):864-76.

PMID:
16721864
13.

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

Cham F, Zhang PF, Heyndrickx L, Bouma P, Zhong P, Katinger H, Robinson J, van der Groen G, Quinnan GV Jr.

Virology. 2006 Mar 30;347(1):36-51. Epub 2005 Dec 27.

14.

Acute non-cardiogenic pulmonary edema in a 2003 French Puumala virus case: cautions and corrections.

Clement J, van der Groen G, Lameire N, Colson P, Van Ranst M.

Clin Nephrol. 2004 May;61(5):364-5; author reply 366. No abstract available.

PMID:
15182134
15.

Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.

Njai HF, Van der Auwera G, Ngong CA, Heyndrickx L, Sawadago S, Whittle H, Nyambi P, Colebunders R, van der Groen G, Janssens W.

J Clin Microbiol. 2004 Apr;42(4):1428-33.

16.

Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120.

Davis D, Donners H, Willems B, Lövgren-Bengtsson K, Akerblom L, Vanham G, Barnett S, Morein B, Heeney JL, van der Groen G.

Vaccine. 2004 Jan 26;22(5-6):747-54.

PMID:
14741168
17.
18.
19.
20.

Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.

Donners H, Davis D, Willems B, van der Groen G.

J Med Virol. 2003 Feb;69(2):173-81.

PMID:
12683404
21.

Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.

Ondoa P, Vereecken C, Fransen K, Colebunders R, van der Groen G, Heeney JL, Kestens L.

J Med Virol. 2003 Mar;69(3):297-305.

PMID:
12526038
22.

Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.

Van Herrewege Y, Penne L, Vereecken C, Fransen K, van der Groen G, Kestens L, Balzarini J, Vanham G.

AIDS Res Hum Retroviruses. 2002 Oct 10;18(15):1091-102.

PMID:
12396448
23.

Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV.

Beelaert G, Vercauteren G, Fransen K, Mangelschots M, De Rooy M, Garcia-Ribas S, van der Groen G.

J Virol Methods. 2002 Sep;105(2):197-206.

PMID:
12270653
24.

In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells.

Ondoa P, Davis D, Kestens L, Vereecken C, Garcìa Ribas S, Fransen K, Heeney J, van der Groen G.

J Med Virol. 2002 Jul;67(3):301-11.

PMID:
12116019
25.

Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Boutonnet N, Janssens W, Boutton C, Verschelde JL, Heyndrickx L, Beirnaert E, van der Groen G, Lasters I.

J Virol. 2002 Aug;76(15):7595-606.

26.

Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees.

Ondoa P, Kestens L, Davis D, Vereecken C, Willems B, Fransen K, Vingerhoets J, Zissis G, ten Haaft P, Heeney J, van der Groen G.

J Med Primatol. 2001 Oct;30(5):243-53.

PMID:
11990239
27.

In vitro replication of SIVcpz is suppressed by beta-chemokines and CD8+ T cells but not by natural killer cells of infected chimpanzees.

Ondoa P, Vingerhoets J, Vereecken C, van der Groen G, Heeney JL, Kestens L.

AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):373-82.

PMID:
11897039
28.

Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1.

Donners H, Willems B, Beirnaert E, Colebunders R, Davis D, van der Groen G.

AIDS. 2002 Feb 15;16(3):501-3. No abstract available.

PMID:
11834970
29.

Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally.

Ondoa P, Davis D, Willems B, Heyndrickx L, Kestens L, van der Berg I, Coppens S, Janssens W, Heeney J, van der Groen G.

J Med Virol. 2001 Dec;65(4):765-76.

PMID:
11745943
30.
31.

HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa.

Morison L, Buvé A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, Kahindo M, Weiss HA, Hayes RJ, Laga M, Janssens W, van der Groen G; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S109-16.

PMID:
11686459
32.

Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.

ten Haaft P, Murthy K, Salas M, McClure H, Dubbes R, Koornstra W, Niphuis H, Davis D, van der Groen G, Heeney J.

AIDS. 2001 Nov 9;15(16):2085-92.

PMID:
11684927
33.

[Analysis of gag gene subtypes of HIV-1 variants isolated in Russia by comparative assessment of heteroduplex electrophoretic mobility].

Kazennova EV, Bobkov AF, Selimova LM, Khanina TA, Pokrovskiĭ VV, Heyndrickx L, Van der Groen G.

Vopr Virusol. 2001 May-Jun;46(3):12-6. Russian.

PMID:
11450137
34.

Evaluation of four HIV antigen tests.

Fransen K, Beelaert G, van der Groen G.

J Virol Methods. 2001 Apr;93(1-2):189-93.

PMID:
11311358
35.

Quantitative assay for group M (subtype A-H) and group O HIV-1 RNA detection in plasma.

Ernest I, Alexandre I, Zammatteo N, Herman M, Houbion A, De Leener F, Fransen K, van der Groen G, Remacle J.

J Virol Methods. 2001 Apr;93(1-2):1-14.

PMID:
11311338
36.
37.

Genetic characterization of Puumala hantavirus strains from Belgium: evidence for a distinct phylogenetic lineage.

Escutenaire S, Chalon P, Heyman P, Van der Auwera G, van der Groen G, Verhagen R, Thomas I, Karelle-Bui L, Vaheri A, Pastoret PP, Plyusnin A.

Virus Res. 2001 Apr;74(1-2):1-15.

PMID:
11226569
38.

Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program.

Van der Auwera G, Janssens W, Heyndrickx L, van der Groen G.

AIDS Res Hum Retroviruses. 2001 Jan 20;17(2):185-9.

PMID:
11177398
39.

Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium.

Sasse A, Liesnard C, van der Groen G, Burtonboy G, Plum J, Sondag-Thull D, Sprecher S, Van Ranst M, Zissis G, Desmyter J.

AIDS. 2000 Dec 1;14(17):2798-800. No abstract available.

PMID:
11125905
40.

Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction.

Cham F, Heyndrickx L, Janssens W, Van der Auwera G, Vereecken K, De Houwer K, Coppens S, Whittle H, van der Groen G.

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1915-9.

PMID:
11118077
41.

Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation.

Vanham G, Penne L, Allemeersch H, Kestens L, Willems B, van der Groen G, Jeang KT, Toossi Z, Rich E.

AIDS. 2000 Oct 20;14(15):2299-311.

PMID:
11089618
42.

Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments.

Cham F, Heyndrickx L, Janssens W, Vereecken K, De Houwer K, Coppens S, Van der Auwera G, Whittle H, van der Groen G.

AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1503-5.

PMID:
11054263
43.

Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.

de Baar MP, Janssens W, de Ronde A, Fransen K, Colebunders R, Kestens L, van der Groen G, Goudsmit J.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1385-94.

PMID:
11018858
44.

Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones.

Vanham G, Davis D, Willems B, Penne L, Kestens L, Janssens W, van der Groen G.

AIDS. 2000 Aug 18;14(12):1874-6. No abstract available.

PMID:
10985336
45.

HIV-1 genetic variability in Cameroon.

Heyndrickx L, Janssens W, Ndumbe PM, Vereecken K, Coppens S, De Houwer K, Fransen K, Van der Auwera G, van der Groen G.

AIDS. 2000 Aug 18;14(12):1862-4. No abstract available.

PMID:
10985330
46.

HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants.

Janssens W, Laukkanen T, Salminen MO, Carr JK, Van der Auwera G, Heyndrickx L, van der Groen G, McCutchan FE.

AIDS. 2000 Jul 28;14(11):1533-43.

PMID:
10983640
47.

A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.

Quiñones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, Vanham G, van Der Groen G, Colebunders RL, Arts EJ.

J Virol. 2000 Oct;74(19):9222-33.

48.

Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants.

Janssens W, Salminen MO, Laukkanen T, Heyndrickx L, van der Auwera, Colebunders R, McCutchan FE, van der Groen G.

AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1183-9.

PMID:
10954895
49.

Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.

Beirnaert E, Nyambi P, Willems B, Heyndrickx L, Colebunders R, Janssens W, van der Groen G.

J Med Virol. 2000 Sep;62(1):14-24.

PMID:
10935983
50.

Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O.

Yang C, Gao F, Fonjungo PN, Zekeng L, van der Groen G, Pieniazek D, Schable C, Lal RB.

AIDS Res Hum Retroviruses. 2000 Jul 20;16(11):1075-81.

PMID:
10933623

Supplemental Content

Loading ...
Support Center